Attia M, Kijanka G, Nguyen N, Zhang J, An H
Acta Pharm Sin B. 2025; 15(1):52-96.
PMID: 40041887
PMC: 11873661.
DOI: 10.1016/j.apsb.2024.09.009.
Ahuja S, Zaheer S
Korean J Clin Oncol. 2025; 20(2):51-73.
PMID: 39778508
PMC: 11717579.
DOI: 10.14216/kjco.24009.
Omole A, Zhao Z, Chang-Liao S, de Oliveira J, Boone C, Sutorus L
Nat Rev Bioeng. 2024; 2(11):916-929.
PMID: 39698315
PMC: 11655125.
DOI: 10.1038/s44222-024-00231-z.
Huang H, Narayanan H, Hoffmann A
bioRxiv. 2024; .
PMID: 39131345
PMC: 11312454.
DOI: 10.1101/2024.07.28.605521.
Emens L, Romero P, Anderson A, Bruno T, Capitini C, Collyar D
J Immunother Cancer. 2024; 12(6).
PMID: 38901879
PMC: 11191773.
DOI: 10.1136/jitc-2024-009063.
The senescence journey in cancer immunoediting.
Zingoni A, Antonangeli F, Sozzani S, Santoni A, Cippitelli M, Soriani A
Mol Cancer. 2024; 23(1):68.
PMID: 38561826
PMC: 10983694.
DOI: 10.1186/s12943-024-01973-5.
Aerobic glycolysis enables the effector differentiation potential of stem-like CD4 T cells to combat cancer.
Zou D, Zhang X, Li S, Xiao X, Gonzalez N, Minze L
Cell Mol Immunol. 2024; 21(5):527-529.
PMID: 38514872
PMC: 11061150.
DOI: 10.1038/s41423-024-01154-w.
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives.
Uher O, Hadrava Vanova K, Taieb D, Calsina B, Robledo M, Clifton-Bligh R
Endocr Rev. 2024; 45(4):521-552.
PMID: 38377172
PMC: 11244254.
DOI: 10.1210/endrev/bnae005.
Peto's "Paradox" and Six Degrees of Cancer Prevalence.
Szasz A
Cells. 2024; 13(2).
PMID: 38275822
PMC: 10814230.
DOI: 10.3390/cells13020197.
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit.
Kostecki K, Iida M, Crossman B, Salgia R, Harari P, Bruce J
Cancers (Basel). 2024; 16(2).
PMID: 38254801
PMC: 10814769.
DOI: 10.3390/cancers16020312.
Cancer vaccines: from an immunology perspective.
Makker S, Galley C, Bennett C
Immunother Adv. 2024; 4(1):ltad030.
PMID: 38223410
PMC: 10787373.
DOI: 10.1093/immadv/ltad030.
Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer.
Liu D, Che X, Wang X, Ma C, Wu G
Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895855
PMC: 10610367.
DOI: 10.3390/ph16101384.
Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance.
Mamat Yusof M, Chew K, Kampan N, Shafiee M
Int J Mol Sci. 2023; 24(20).
PMID: 37894913
PMC: 10607163.
DOI: 10.3390/ijms242015233.
The Immune Cells in the Development of Oral Squamous Cell Carcinoma.
Caponio V, Zhurakivska K, Lo Muzio L, Troiano G, Cirillo N
Cancers (Basel). 2023; 15(15).
PMID: 37568595
PMC: 10417065.
DOI: 10.3390/cancers15153779.
T Cell Based Immunotherapy for Cancer: Approaches and Strategies.
Want M, Bashir Z, Najar R
Vaccines (Basel). 2023; 11(4).
PMID: 37112747
PMC: 10142387.
DOI: 10.3390/vaccines11040835.
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies.
Sei S, Ahadova A, Keskin D, Bohaumilitzky L, Gebert J, von Knebel Doeberitz M
Front Oncol. 2023; 13:1147590.
PMID: 37035178
PMC: 10073468.
DOI: 10.3389/fonc.2023.1147590.
Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer.
Jin H, Liao S, Yao F, Li J, Xu Z, Zhao K
Cancers (Basel). 2023; 15(5).
PMID: 36900322
PMC: 10000400.
DOI: 10.3390/cancers15051532.
Highlights into historical and current immune interventions for cancer.
Cole K, Al-Kadhimi Z, Talmadge J
Int Immunopharmacol. 2023; 117:109882.
PMID: 36848790
PMC: 10355273.
DOI: 10.1016/j.intimp.2023.109882.
Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy.
Biri-Kovacs B, Banoczi Z, Tummalapally A, Szabo I
Pharmaceutics. 2023; 15(2).
PMID: 36839774
PMC: 9963291.
DOI: 10.3390/pharmaceutics15020452.
Cancer-Associated B Cells in Sarcoma.
Kendal J, Shehata M, Lofftus S, Crompton J
Cancers (Basel). 2023; 15(3).
PMID: 36765578
PMC: 9913500.
DOI: 10.3390/cancers15030622.